Yasmina Bendacha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yasmina Bendacha has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Jean-Marc Catheline
Department of Digestive Surgery, Centre Hospitalier de Saint-Denis, 2 rue du Docteur Delafontaine, 93200 Saint-Denis, France
3 shared publications - Joel Roussel
Department of Digestive Surgery, Centre Hospitalier de Saint-Denis, 2 rue du Docteur Delafontaine, 93200 Saint-Denis, France
3 shared publications - Rami Dbouk
Department of Digestive Surgery, Centre Hospitalier de Saint-Denis, 2 rue du Docteur Delafontaine, 93200 Saint-Denis, France
2 shared publications - Régis Cohen
Department of Digestive Surgery, Centre Hospitalier de Saint-Denis, Saint-Denis, France
2 shared publications - Elie Chouillard
Departement de Chirurgie Digestive, Centre Hospitalier Intercommunal de Poissy/Saint-Germain-en-Laye 10, Rue du Champ Gaillard, 78300 Poissy, France
1 shared publication - Eric Vicaut
AP-HP, Saint Louis/Lariboisière Hospitals, Unité de recherche clinique and Université Paris 7
1 shared publication
Latest Publications
- Open Access
- 13 September 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (12) , 4145-4150
Re-sleeve gastrectomy is a safe and sensible intervention in selected patients: retrospective cohort study
Introduction: Sleeve gastrectomy is a good treatment intervention to control the metabolic syndrome in patients with obesity worldwide. However, weight regain is of great concern and would usually necessitate a reintervention. In recent years, re-sleeve gastrectomy (ReSG) has been proposed to treat weight regain in the context of a large residual stomach. Our objective was to analyze the long-term results and safety profile of this intervention in a large case series. Methods: From September 2010 to March 2021, a retrospective cohort study in a tertiary nonuniversity hospital was performed. Seventy-nine patients received a ReSG by laparoscopy. Preoperative radiologic imaging showed a dilation of the gastric pouch exceeding 250 cc in all cases. Results: A total of 79 patients (87% females) with a mean age of 44.8 years old and a mean BMI of 40.0 kg/m2 were enrolled in the study. The mean follow-up was 44.8 months. The ReSG indication was insufficient weight loss in 37 patients (46.8%) and weight regain in 39 patients (53.2%). The authors noticed a 10.1% complications rate: gastric stenosis (5.1%), bleeding (2.5%), and incisional site hernia in 2.5%, with no death. There was no gastric fistula detected. The mean BMI decreased to 33.1 kg/m2 after ReSG (a decrease of 6.9 kg/m2). Conclusion: After insufficient weight loss or weight regain following sleeve gastrectomy and in the presence of localized or global gastric tube dilation, ReSG seems to be a good treatment choice and a safe procedure.
- 13 September 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (12) , 4145-4150
Open AccessRe-sleeve gastrectomy is a safe and sensible intervention in selected patients: retrospective cohort study
Introduction: Sleeve gastrectomy is a good treatment intervention to control the metabolic syndrome in patients with obesity worldwide. However, weight regain is of great concern and would usually necessitate a reintervention. In recent years, re-sleeve gastrectomy (ReSG) has been proposed to treat weight regain in the context of a large residual stomach. Our objective was to analyze the long-term results and safety profile of this intervention in a large case series. Methods: From September 2010 to March 2021, a retrospective cohort study in a tertiary nonuniversity hospital was performed. Seventy-nine patients received a ReSG by laparoscopy. Preoperative radiologic imaging showed a dilation of the gastric pouch exceeding 250 cc in all cases. Results: A total of 79 patients (87% females) with a mean age of 44.8 years old and a mean BMI of 40.0 kg/m2 were enrolled in the study. The mean follow-up was 44.8 months. The ReSG indication was insufficient weight loss in 37 patients (46.8%) and weight regain in 39 patients (53.2%). The authors noticed a 10.1% complications rate: gastric stenosis (5.1%), bleeding (2.5%), and incisional site hernia in 2.5%, with no death. There was no gastric fistula detected. The mean BMI decreased to 33.1 kg/m2 after ReSG (a decrease of 6.9 kg/m2). Conclusion: After insufficient weight loss or weight regain following sleeve gastrectomy and in the presence of localized or global gastric tube dilation, ReSG seems to be a good treatment choice and a safe procedure.
- 1 February 2022
- Published by Elsevier in Journal of Visceral Surgery
- Vol. 159 (1) , 39-42
Long-term endoscopic follow-up after sleeve gastrectomy
- 1 February 2022
- Published by Elsevier in Journal of Visceral Surgery
- Vol. 159 (1) , 39-42
Long-term endoscopic follow-up after sleeve gastrectomy
- 1 December 2019
- Published by Elsevier in Journal of Visceral Surgery
- Vol. 156 (6) , 497-506
Prospective, multicentric, comparative study between sleeve gastrectomy and Roux-en-Y gastric bypass, 277 patients, 3 years follow-up
- 1 December 2019
- Published by Elsevier in Journal of Visceral Surgery
- Vol. 156 (6) , 497-506
Prospective, multicentric, comparative study between sleeve gastrectomy and Roux-en-Y gastric bypass, 277 patients, 3 years follow-up